1247884-05-4

Basic information

• Product Name: (+/-)-benzyl 5-hydroxy-2-methyl-4-picolinamidopiperidine-1-carboxylate
• Synonyms: (+/-)-benzyl 5-hydroxy-2-methyl-4-picolinamidopiperidine-1-carboxylate
• CAS NO: 1247884-05-4
• Molecular Weight: 369.42
• Mol File: 1247884-05-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (+/-)-benzyl 5-hydroxy-2-methyl-4-picolinamidopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-benzyl 5-hydroxy-2-methyl-4-picolinamidopiperidine-1-carboxylate(1247884-05-4)
• EPA Substance Registry System: (+/-)-benzyl 5-hydroxy-2-methyl-4-picolinamidopiperidine-1-carboxylate(1247884-05-4)

Safety Data

• Hazardous Substances Data: 1247884-05-4(Hazardous Substances Data)

Upstream product

• 98-98-6 2-Picolinic acid 
• 1247884-04-3 benzyl 4-amino-5-hydroxy-2-methylpiperidine-1-carboxylate 

Downstream Products

• 1247884-07-6 (+/-)-benzyl 2-methyl-5-oxo-4-picolinamidopiperidine-1-carboxylate 

Relevant articles and documents

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF

Provided herein are compounds and methods of synthesis thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders, psychiatric disorders, neuromuscular disorders, gastrointestinal disorders, lower urinary tract disorder, and cancer. Compounds provided herein modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery. Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.